These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Lin M, Wong C, Lin P, Shon IH, Cuganesan R, Som S. Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328 [Abstract] [Full Text] [Related]
11. Thyroid Incidentalomas Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography: Malignant Risk Stratification and Management Plan. Chung SR, Choi YJ, Suh CH, Kim HJ, Lee JJ, Kim WG, Sung TY, Lee YM, Song DE, Lee JH, Baek JH. Thyroid; 2018 Jun; 28(6):762-768. PubMed ID: 29759033 [Abstract] [Full Text] [Related]
12. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287 [Abstract] [Full Text] [Related]
14. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients. Yoon JH, Cho A, Lee HS, Kim EK, Moon HJ, Kwak JY. Surgery; 2015 Nov; 158(5):1314-22. PubMed ID: 25958065 [Abstract] [Full Text] [Related]
16. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients. Barrio M, Czernin J, Yeh MW, Palma Diaz MF, Gupta P, Allen-Auerbach M, Schiepers C, Herrmann K. Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034 [Abstract] [Full Text] [Related]
17. 18F-FDG-Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation. Pattison DA, Bozin M, Gorelik A, Hofman MS, Hicks RJ, Skandarajah A. J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986 [Abstract] [Full Text] [Related]
18. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer. Eloy JA, Brett EM, Fatterpekar GM, Kostakoglu L, Som PM, Desai SC, Genden EM. AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543 [Abstract] [Full Text] [Related]
19. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Salvatori M, Melis L, Castaldi P, Maussier ML, Rufini V, Perotti G, Rubello D. Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940 [Abstract] [Full Text] [Related]